🩸 Anticoagulant-Related Major Bleeding Reversal
This tool gives the specific reversal agent and general hemostatic support for anticoagulant-related major bleeding, by anticoagulant class.
Clinical takeaway
Specific antidotes are layered on top of universal first steps (stop the drug, mechanical hemostasis, transfusion support), not used in isolation. (original synthesis · not guideline verbatim)
Loading calculator…
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
When to use
Use in major or life-threatening bleeding to pair the correct antidote with the drug class while applying general measures and planning restart.
How it works
VKA → vitamin K + 4F-PCC (or FFP). Dabigatran → idarucizumab (or PCC/dialysis). Xa inhibitor → andexanet alfa (or 4F-PCC). Heparin → protamine (1 mg per ~100 U).
Key points
- Specific antidotes are layered on top of universal first steps (stop the drug, mechanical hemostasis, transfusion support), not used in isolation. (original synthesis · not guideline verbatim)
- Dabigatran is dialyzable, offering an additional removal route unavailable for the Xa inhibitors.
- After bleeding control, restart timing weighs thrombotic risk (e.g. mechanical valve favors earlier restart).
References
Decision support for licensed clinicians only; not a substitute for clinical judgement, diagnosis or local protocols.
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Anticoagulant class | Warfarin / vitamin K antagonist |
|---|
→Antidote/reversalVitamin K + 4F-PCC
- Specific/preferred reversal：IV vitamin K 5–10 mg + 4-factor prothrombin complex concentrate (4F-PCC, by INR/weight); fresh frozen plasma (FFP) if no PCC available
- General measures：Stop the anticoagulant immediately; mechanical/endoscopic/surgical/interventional hemostasis; transfusion and volume support, correct other coagulation abnormalities (platelets, fibrinogen); activated charcoal for recent oral anticoagulant
- After bleeding control：Assess thromboembolic risk and timing of anticoagulation restart (e.g. mechanical valve or recent high-risk VTE need earlier restart; low risk can defer or stop)
| Anticoagulant class | Heparin / low-molecular-weight heparin |
|---|
→Antidote/reversalProtamine
- Specific/preferred reversal：Unfractionated heparin: full neutralization with protamine (1 mg reverses ~100 U heparin); LMWH: partial neutralization with protamine
- General measures：Stop the anticoagulant immediately; mechanical/endoscopic/surgical/interventional hemostasis; transfusion and volume support, correct other coagulation abnormalities (platelets, fibrinogen); activated charcoal for recent oral anticoagulant
- After bleeding control：Assess thromboembolic risk and timing of anticoagulation restart (e.g. mechanical valve or recent high-risk VTE need earlier restart; low risk can defer or stop)
Frequently asked questions
- What is Anticoagulant-Related Major Bleeding Reversal?
- This tool gives the specific reversal agent and general hemostatic support for anticoagulant-related major bleeding, by anticoagulant class.
- How is Anticoagulant-Related Major Bleeding Reversal calculated? What is the core formula?
- VKA → vitamin K + 4F-PCC (or FFP). Dabigatran → idarucizumab (or PCC/dialysis). Xa inhibitor → andexanet alfa (or 4F-PCC). Heparin → protamine (1 mg per ~100 U).
- When is Anticoagulant-Related Major Bleeding Reversal used?
- Use in major or life-threatening bleeding to pair the correct antidote with the drug class while applying general measures and planning restart.
- What are the key clinical points for Anticoagulant-Related Major Bleeding Reversal?
- Specific antidotes are layered on top of universal first steps (stop the drug, mechanical hemostasis, transfusion support), not used in isolation. (original synthesis · not guideline verbatim) Dabigatran is dialyzable, offering an additional removal route unavailable for the Xa inhibitors. After bleeding control, restart timing weighs thrombotic risk (e.g. mechanical valve favors earlier restart).
- What are the limits and cautions when using Anticoagulant-Related Major Bleeding Reversal?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- How is Anticoagulant-Related Major Bleeding Reversal calculated in practice? Can you show a worked example?
- Inputs: Anticoagulant class Warfarin / vitamin K antagonist → Result: Antidote/reversal Vitamin K + 4F-PCC（Specific/preferred reversal: IV vitamin K 5–10 mg + 4-factor prothrombin complex concentrate (4F-PCC, by INR/weight); fresh frozen plasma (FFP) if no PCC available, General measures: Stop the anticoagulant immediately; mechanical/endoscopic/surgical/interventional hemostasis; transfusion and volume support, correct other coagulation abnormalities (platelets, fibrinogen); activated charcoal for recent oral anticoagulant, After bleeding control: Assess thromboembolic risk and timing of anticoagulation restart (e.g. mechanical valve or recent high-risk VTE need earlier restart; low risk can defer or stop)） Inputs: Anticoagulant class Heparin / low-molecular-weight heparin → Result: Antidote/reversal Protamine（Specific/preferred reversal: Unfractionated heparin: full neutralization with protamine (1 mg reverses ~100 U heparin); LMWH: partial neutralization with protamine, General measures: Stop the anticoagulant immediately; mechanical/endoscopic/surgical/interventional hemostasis; transfusion and volume support, correct other coagulation abnormalities (platelets, fibrinogen); activated charcoal for recent oral anticoagulant, After bleeding control: Assess thromboembolic risk and timing of anticoagulation restart (e.g. mechanical valve or recent high-risk VTE need earlier restart; low risk can defer or stop)）